People channel feed – Endpoints News

People channel feed

Intercept shakeup continues as CMO, former NASH chief resigns. Is the NASH biotech abandoning its flagship disease?

5 years ago

Jim Mullen won a $20M option package when he switched from chairman to the CEO job at Editas — and it's all tied to performance

5 years ago

Kite development head Ken Takeshita jumps to Daiichi Sankyo amid oncology push

5 years ago

Eli Lilly's David Ricks snared $24M pay package in a year turbo-boosted by Covid-19 antibody

5 years ago

Vas Narasimhan gets a bump in pay, but still falls well below some rivals

5 years ago

Endpoints Manufacturing: 5 Questions with Homology Medicines

5 years ago

Janet Woodcock slams calls for FDA 'firewall' amid aducanumab debacle, citing need for collaborative drug development

5 years ago

Eli Lilly adds new board member Kimberly Johnson, the COO who helped lead Fannie Mae out of the US housing crisis

5 years ago

Gene editing expert Charlie Albright tells us why he hopped from Editas to a new role as CSO of an upstart biotech out to engineer gene therapy 2.0

5 years ago

Exclusive: After four decades, one researcher's radical HIV cure finally gets its shot

5 years ago

'I’m not trying to rebuild an ego': Neil Woodford appeals to professionals for his comeback biotech fund

5 years ago

AstraZeneca's Pascal Soriot picks up $21.5M pay package in 2020, a big haul in year marked by Covid-19 shot development

5 years ago

Eli Lilly strips ousted CFO Josh Smiley of $24M in pay after 'inappropriate messages' scandal

5 years ago

SR One recruits an IPO vet and seasoned ops chief for the venture team. And they have some practical advice for you

5 years ago

Months after shocking house arrest, Legend co-founder Frank Zhang is out on bail — though the CAR-T player has moved on

5 years ago

Eli Lilly ousts CFO Josh Smiley after 'inappropriate relationship' with employee, appoints successor in Anat Ashkenazi

5 years ago

Mark Mallon wraps a short stint as CEO of Ironwood, jumping out to pursue 'multiple passions' in the wake of setbacks

5 years ago

Former Galena chief Mark Ahn back in hot water as DOJ levels insider trading charges for consultant work

5 years ago

Ex-Biogen CEO Jim Mullen steps back to the helm of a biotech, and once again he has a critical challenge to confront

5 years ago

'Can't say no': Kite Pharma taps Frank Neumann as new head of clinical development

5 years ago

'Gene therapy is at an inflection point': Kathy High on her new perch at AskBio and the field's future

5 years ago

Merck CEO Ken Frazier prepares to step down after 29 years, handing the keys to the Keytruda race car to CFO Robert Davis

5 years ago

Mads Krogsgaard Thomsen hands off CSO job at Novo Nordisk after a 30-year run, then pivots to CEO post at huge Novo Foundation

5 years ago

Biotech scandal drags on as the feds only score partial victory against execs charged with cooking the books

5 years ago

First page Previous page 61 62 636465 66 67 Next page Last page